Cost-Effectiveness of Reimbursing Infliximab for Moderate...

  • Main
  • 2019 / 12
  • Cost-Effectiveness of Reimbursing Infliximab for Moderate...
Advances in Therapy 2019 / 12

Cost-Effectiveness of Reimbursing Infliximab for Moderate to Severe Crohn’s Disease in China

Chen, Haotian, Shi, Jihao, Pan, Yipeng, Zhang, Zhou, Fang, Hao, Chen, Ying, Chen, Wendong, Cao, Qian
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
Advances in Therapy
DOI:
10.1007/s12325-019-01150-x
Date:
December, 2019
File:
PDF, 814 KB
2019
Conversion to is in progress
Conversion to is failed